What class is the HARNESSING NEXT-GENERATION SIRNA ENGINEERING trademark registered in?

The HARNESSING NEXT-GENERATION SIRNA ENGINEERING trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

What is the serial number for HARNESSING NEXT-GENERATION SIRNA ENGINEERING?

The USPTO serial number for HARNESSING NEXT-GENERATION SIRNA ENGINEERING is 98789220.

What is the registration number for HARNESSING NEXT-GENERATION SIRNA ENGINEERING?

HARNESSING NEXT-GENERATION SIRNA ENGINEERING is registered under USPTO registration number 0.

HAR

USPTO Trademark Record

PENDING

HARNESSING NEXT-GENERATION SIRNA ENGINEERING

SN 98789220·Reg 0·Filed Oct 07, 2024

Owner City Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

HARNESSING NEXT-GENERATION SIRNA ENGINEERING (Serial No. 98789220), Registration No. 0, is a pending US trademark filed on Oct 07, 2024 by City Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Statement of Use due: January 15, 2027103 days remaining

Mark Intelligence

HARNESSING NEXT-GENERATION SIRNA ENGINEERING (Reg. #0) is a pending US trademark that was filed in 2024 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 07, 2024

SERIAL

98789220

REG#

Owner

Applicant

City Therapeutics, Inc.

Entity

Corporation

State

Address

399 Binney Street, Cambridge, MA, 02141

Country

Attorney

NamePatrick J. Concannon

Law firm

Patrick J. Concannon Nutter, McClennen & Fish, LLP

Docket

127365-60006

Address

Seaport West, 155 Seaport Boulevard, Boston, MA 02210, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateOct 07, 2024

Serial Number98789220

Registration No.0

Status DateJun 18, 2026

Published for OppositionMay 20, 2025

Mark TypeStandard characters

Attorney Docket127365-60006

Status DescriptionLive and pending, second extension granted

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

20 events

SOU TEAS EXTENSION RECEIVED

Jun 18, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jun 18, 2026

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Jun 18, 2026

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 18, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 10, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 09, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 09, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Dec 09, 2025

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 15, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 20, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 20, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 14, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Apr 22, 2025

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Apr 22, 2025

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 22, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Apr 22, 2025

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 22, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Apr 10, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 09, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 07, 2024

NEW APPLICATION ENTERED

HARNESSING NEXT-GENERATION SIRNA ENGINEERING

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by City Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Patrick J. Concannon

Resources

Company